FDA approves first drug-coated balloon; Delivery biz PolyPid files IPO;

> C.R. Bard's ($BCR) Lutonix 035 Drug Coated Balloon Catheter became the first drug-coated balloon to receive PMA approval from the FDA on Oct. 10. It is indicated for the reopening of narrowed or blocked arteries in the knee or thigh in patients with peripheral artery disease (PAD). Story

> PolyPid, developer of a clinical-stage antibiotic coating for bone repair, just filed for a $24 million IPO with the Securities and Exchange Commission. Story

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.